High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma

British Journal of Cancer

Volumn 91, Issue 5, 2004, Pages 972-979

  Hiyama, E ^a,b,c   Yamaoka, H ^b   Matsunaga, T ^c   Hayashi, Y ^c   Ando, H ^c   Suita, S ^c   Horie, H ^c   Kaneko, M ^c   Sasaki, F ^c   Hashizume, K ^c   Nakagawara, A ^c   Ohnuma, N ^c   Yokoyama, T ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Japan Stud Grp Pediat Liver Tum   (Japan)

Author keywords

Hepatoblastoma; Human telomerase reverse transcriptase; Indicator; LightCycler; Prognosis; Telomerase

Indexed keywords

MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADOLESCENT; ARTICLE; CATALYSIS; CELL IMMORTALIZATION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME ACTIVITY; EVALUATION; FEMALE; FLUORESCENCE; HEPATOBLASTOMA; HUMAN; INFANT; LIVER TUMOR; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; HEPATOBLASTOMA; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 4644297399     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602054     Document Type: Article

References (46)

1. Albrecht S, von Schweinitz D, Waha A, Kraus JA, von Deimling A, Pietsch T (1994) Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res 54: 5041-5044
2. Blackburn EH (1991) Structure and function of telomeres. Nature (London) 350: 569-573
3. Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, Dicks-Mireaux C, Phillips A, Vos A, Plaschkes J (2000) Pretreatment prognostic factors for children with hepatoblastoma - results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36: 1418-1425
4. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S (1995) Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55: 2533-2536
5. Chou SJ, Chen CM, Harn HJ, Chen CJ, Liu YC (2001) In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma. J Surg Res 99: 75-83
6. Chromzynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate phenol-chloroform extraction. Anal Biochem 162: 156-159
7. Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, Grundy PE, Perlman EJ, Breslow NE, Sukumar S (1999) High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor. Cancer Res 59: 4301-4307
8. Finegold MJ (2002) Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice. Med Pediatr Oncol 39: 484-486
9. Fuchs J, Rydzynski J, Von Schweinitz D, Bode U, Hecker H, Weinel P, Burger D, Harms D, Erttmann R, Oldhafer K, Mildenberger H (2002) Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95: 172-182
10. Gupta J, Han LP, Wang P, Gallie BL, Bacchetti S (1996) Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst 88: 1152-1157
11. Haas JE, Muczynski KA, Krailo M, Ablin A, Land V, Vietti TJ, Hammond GD (1989) Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64: 1082-1095
12. Hata Y (1990) The clinical features and prognosis of hepatoblastoma: follow-up studies done on pediatric tumors enrolled in the Japanese pediatric tumor registry between 1971 and 1980. Part I. committee of malignant tumors, Japanese Society of Pediatric Surgeons. Jpn J Surg 20: 498-502
13. Harley CB, Kim NW, Prowse KL, Weinrich SL, Hirsh KS, West MD, Bacchetti S, Hirre HW, Counter CM, Greider CW, Piatyszek MA, Wright WE, Shay JW (1994) Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol 59: 307-315
14. Hiyama E, Hiyama K (2002) Clinical utility of telomerase in cancer. Oncogene 21: 643-649
15. Hiyama E, Hiyama K (2003) Telomerase as tumor marker. Cancer Lett 194: 221-233
16. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T (1997a) Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behavior? Eur J Cancer 33: 1932-1936
17. Hiyama E, Hiyama K, Shay JW, Yokoyama T (2001) Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3: 17-26
18. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW (1995a) Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1: 249-255
19. Hiyama E, Kodama T, Sinbara K, Iwao T, Itoh M, Hiyama K, Shay JW, Matsuura Y, Yokoyama T (1997b) Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57: 326-331
20. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y (1995b) Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262
21. Iwao T, Hiyama E, Yokoyama T, Tsuchida A, Hiyama K, Murakami Y, Shimamoto F, Shay JW, Kajiyama G (1997) Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst 89: 1621-1623
22. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
23. Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T (1999) Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res 59: 269-273
24. Kotoula V, Hytiroglou P, Pyrpasopoulou A, Saxena R, Thung SN, Papadimitriou CS (2002) Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver 22: 57-69
25. Kumaki F, Kawai T, Hiroi S, Shinomiya N, Ozeki Y, Ferrans VJ, Torikata C (2001) Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum Pathol 32: 188-195
26. Marchetti A, Bertacca G, Buttitta F, Chella A, Quattrocolo G, Angeletti CA, Bevilacqua G (1999) Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res 5: 2077-2081
27. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC (2003) Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253
28. Naito Y, Takagi T, Handa O, Ishikawa T, Matsumoto N, Yoshida N, Kato H, Ando T, Takemura T, Itani K, Hisatomi H, Tsuchihashi Y, Yoshikawa T (2001) Telomerase activity and expression of telomerase RNA component and catalytic subunits in precancerous and cancerous colorectal lesions. Tumour Biol 22: 374-382
29. Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G (1997) Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 74: 141-147
30. Nishimura S, Sato T, Fujita N, Yamaoka H, Hiyama E, Yokoyama T, Ueda K (2002) High-dose chemotherapy in children with metastatic hepatoblastoma. Pediatr Int 44: 300-305
31. Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, Ashida K, Kinugasa N, Yoshida K, Uematsu S, Tsuji T (1996) Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 78: 232-236
32. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE, Shay JW (1995) Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17: 1-15
33. Samuel DP, Tsokos M, DeBaun MR (1999) Hemihypertrophy and a poorly differentiated embryonal rhabdomyosarcoma of the pelvis. Med Pediatr Oncol 32: 38-43
34. Saretzki G (2003) Telomerase inhibition as cancer therapy. Cancer Lett 194: 209-219
35. Sasaki F, Matsunaga T, Iwafuchi M, Hayashi Y, Ohkawa H, Ohira M, Okamatsu T, Sugito T, Tsuchida Y, Toyosaka A, Nagahara N, Nishihira H, Hata Y, Uchino J, Misugi K, Ohnuma N (2002) Outcome of hepatoblastoma treated with the JPLT-1 (Japanese study group for pediatric liver tumor) protocol-1: a report from the Japanese study group for pediatric liver tumor. J Pediatr Surg 37: 851-856
36. Shay JW (1995) Aging and cancer: are telomeres and telomerase the connection? Molec Med Today 1: 378-384
37. Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791
38. Shay JW, Werbin H, Wright WE (1997) Telomerase assay in the diagnosis and prognosis of cancer. Ciba Found Symp 211: 148-155
39. Takayasu H, Horie H, Hiyama E, Matsunaga T, Hayashi Y, Watanabe Y, Suita S, Kaneko M, Sasaki F, Hashizume K, Ozaki T, Furuuchi K, Tada M, Ohnuma N, Nakagawara A (2001) Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin Cancer Res 7: 901-908
40. Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsuura Y, Yokoyama T (2000) High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res 6: 2696-2701
41. von Schweinitz D, Hecker H, Schmidt-von-Arndt G, Harms D (1997) Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer 74: 593-599
42. von Schweinitz D, Kraus JA, Albrecht S, Koch A, Fuchs J, Pietsch T (2002) Prognostic impact of molecular genetic alterations in hepatoblastoma. Med Pediatr Oncol 38: 104-108
43. Watson JD (1972) Origin of concatemeric T7 DNA. Nat New Biol (London) 239: 197-201
44. Weinberg AG, Finegold MJ (1983) Primary hepatic tumors of childhood. Hum Pathol 14: 512-537
45. Wick M, Zubov D, Hagen G (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232: 97-106
46. Yasui W, Tahara E, Tahara H, Fujimoto J, Naka K, Nakayama J, Ishikawa F, Ide T (1999) Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach. Jpn J Cancer Res 90: 589-595